METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
US Application 16/650,696
Filed on 2020-03-25
Filed on 2020-03-25
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Singapore
11202002635R
Filed on 2018-09-17
11202002635R
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
South Korea
10-2020-7012343
Filed on 2020-04-28
10-2020-7012343
Filed on 2020-04-28
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Japan
2020-517553
Filed on 2020-03-26
2020-517553
Filed on 2020-03-26
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Israel
273516
Filed on 2020-03-23
273516
Filed on 2020-03-23
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
European Patent
18782605.2
Filed on 2018-09-17
18782605.2
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
China
201880063656.4
Filed on 2018-09-17
201880063656.4
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Canada
3080274
Filed on 2018-09-17
3080274
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Australia
2018342245
Filed on 2018-09-17
2018342245
Filed on 2018-09-17